to Evaluate the Efficacy and Safety of MG4101(Ex Vivo Expanded Allogeneic NK Cell)

Femme et Homme

| Pays :
| Organes :
| Spécialités :

Extrait

To see the safety and efficacy of injecting MG4101 as a secondary treatment after curative liver resection on the patient with advanced HCC who has high risk of recurrence.

Critère d'inclusion

Hepatocellular carcinoma

Liens

nct
ictrp